13,100 Shares in National Health Investors, Inc. $NHI Acquired by Militia Capital Partners LP

Militia Capital Partners LP bought a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 13,100 shares of the real estate investment trust’s stock, valued at approximately $1,041,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewEdge Advisors LLC boosted its stake in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after buying an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in National Health Investors by 9.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after acquiring an additional 21,851 shares during the last quarter. Jane Street Group LLC lifted its holdings in National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after acquiring an additional 65,885 shares during the period. Envestnet Asset Management Inc. grew its stake in shares of National Health Investors by 12.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 10,911 shares of the real estate investment trust’s stock valued at $765,000 after purchasing an additional 1,183 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of National Health Investors by 4.5% during the 2nd quarter. Geode Capital Management LLC now owns 1,232,524 shares of the real estate investment trust’s stock valued at $86,434,000 after purchasing an additional 53,630 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Stock Up 1.3%

NYSE NHI opened at $86.28 on Tuesday. National Health Investors, Inc. has a 52 week low of $66.41 and a 52 week high of $91.38. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $4.17 billion, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 4.61 and a beta of 0.65. The stock’s 50-day moving average price is $83.64 and its 200-day moving average price is $79.47.

National Health Investors (NYSE:NHI) last released its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The firm had revenue of $105.82 million during the quarter, compared to analysts’ expectations of $95.12 million. During the same period in the prior year, the company posted $1.24 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities research analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Tuesday, March 31st will be given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Tuesday, March 31st. National Health Investors’s dividend payout ratio is presently 121.85%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company increased their price objective on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. Truist Financial upped their target price on shares of National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, March 12th. National Bank Financial set a $85.00 price target on shares of National Health Investors in a research report on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price target on shares of National Health Investors in a research note on Monday, January 5th. Finally, KeyCorp boosted their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $86.67.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.